Intracranial low-grade astrocytomas are characterized by mutations in IDH1/2 and high-grade astrocytomas display numerous genetic alterations, including EGFR, p53, hTERT, PTEN and CDKN2A/B34–36. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).